title: The LifeSite hemodialysis access system: implications for the nephrology nurse.
abstract: A new subcutaneous device--the LifeSite Hemodialysis Access System (Vasca, Inc., Tewksbury, MA)--was designed to overcome limitations of transcutaneous dialysis catheters and is now available for use in the United States. A fully implantable device, the LifeSite System provides immediate, reliable, high-flow vascular access. The durable stainless steel and titanium LifeSite valve is implanted in a subcutaneous tissue pocket, typically below the clavicle. It is connected to a biocompatible silicone cannula that is tunneled to a central vein. The device is cannulated using a virtually pain-free, buttonhole technique. The valve is designed to allow cleansing of the valve, valve pocket, and buttonhole site with 70% isopropyl alcohol before and after each use to minimize the risk of infection. One hundred fifty-day results from an ongoing multicenter trial designed to compare the LifeSite System to a Tesio Cath dialysis catheter are reviewed. These results demonstrate that the LifeSite System is associated with statistically significant higher blood flow rates (p < 0.001) and lower rates of adverse events (p < 0.0004), infection (p < 0.032), and thrombolytic infusions (p < 0.044) than a standard dialysis catheter. The positive clinical experience with the LifeSite System carries significant implications for the dialysis team, indicating that this subcutaneous, pain-free route to vascular access may offer a safer, more effective bridge to a permanent arteriovenous (AV) access than a tunneled dialysis catheter. Potential implications of these benefits include improved outcomes, greater convenience for patients, improved efficiency and time management for the nursing staff, along with reduced direct and indirect costs related to vascular access management.
authors.affiliation: Brazos Kidney Disease Center, Waco, TX, USA.
authors.forename: B J
authors.initials: BJ
authors.lastname: Haynes
authors.forename: Anne Walker
authors.initials: AW
authors.lastname: Quarles
authors.forename: Jennifer
authors.initials: J
authors.lastname: Vavrinchik
authors.forename: Jennifer
authors.initials: J
authors.lastname: White
authors.forename: Alex
authors.initials: A
authors.lastname: Pedan
mesh_terms: D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000295:instrumentation / Q000451:nursing*; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000592:standards; D006801:Humans; D006435:Renal Dialysis / Q000295:instrumentation / Q000451:nursing* / Q000592:standards